Literature DB >> 8400799

Perioperative respiratory monitoring of oxygen transport.

F Mertzlufft1, R Zander.   

Abstract

Oximetry nowadays is understood as the in vitro measurement of O2 saturation (sO2, %) and hemoglobin (Hb) derivatives (%) using 4-7 wavelengths (CO- and Hem-oximeters). Pulse oximeters, using only 2 wavelengths, are designed for the continuous noninvasive measurement of the arterial partial O2 saturation (psO2, %) in vivo. Light-emitting diodes allow light to pass through the peripheral site of measurement with red and infrared light to enable a distinction between oxygenated and deoxygenated hemoglobin during a recorded pulse wave. In case of physiological concentrations of Hb derivatives the determination of psO2 is performed with clinically relevant accuracy of +/- 2-3%. However, at carboxyhemoglobin (COHb) concentrations above normal, under normoxia as well as under hypoxia the accuracy of measurement varies considerably among the instruments from different manufacturers. In the case of elevated methemoglobin (MetHb) concentrations, the situation is completely different. With increasing cMetHb, the psO2 is still the value required, but success depends on the concentration of MetHb: under normoxia psO2 is increasingly underestimated, whereas under hypoxia increasing overestimation must be anticipated. Provided there is a constant Hb concentration, knowledge of the initial sO2, and absence of the derivatives COHb and MetHb as well as of severe perfusion disorders, pulse oximetry is suitable for perioperative respiratory monitoring of oxygen transport.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8400799     DOI: 10.1159/000222839

Source DB:  PubMed          Journal:  Infusionsther Transfusionsmed        ISSN: 1019-8466


  1 in total

1.  A multi-channel acoustics monitor for perioperative respiratory monitoring: preliminary data.

Authors:  Kamal Jafarian; Majid Amineslami; Kamran Hassani; Mahdi Navidbakhsh; Mohammad Niakan Lahiji; D John Doyle
Journal:  J Clin Monit Comput       Date:  2015-04-14       Impact factor: 2.502

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.